Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.
International hypoglycaemia study group, and Campbell, Matthew (2017) Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes care, 40 (1). pp. 155-157. ISSN 1935-5548
| Item Type: | Article |
|---|
Abstract
Position Statement
The International Hypoglycaemia Study Group recommends that the frequency of detection of a glucose concentration <3.0 mmol/l (<54 mg/dl), which it considers to be clinically significant biochemical hypoglycaemia, be included in reports of clinical trials of glucose-lowering drugs evaluated for the treatment of diabetes mellitus.
|
PDF
13136.pdf - Published Version Available under License Creative Commons Attribution. Download (317kB) | Preview |
More Information
| Depositing User: Matthew Campbell |
Identifiers
| Item ID: 13136 |
| Identification Number: https://doi.org/10.1007/s00125-016-4146-6 |
| ISSN: 1935-5548 |
| URI: http://sure.sunderland.ac.uk/id/eprint/13136 | Official URL: https://link.springer.com/article/10.1007/s00125-0... |
Users with ORCIDS
Catalogue record
| Date Deposited: 01 Mar 2021 09:36 |
| Last Modified: 01 Mar 2021 09:45 |
| Author: |
Matthew Campbell
|
| Author: | International hypoglycaemia study group |
University Divisions
Faculty of Health Sciences and WellbeingActions (login required)
 |
View Item (Repository Staff Only) |
